Protective role of eicosapentaenoate-lipoate (EPA-LA) derivative in combating oxidative hepatocellular injury in hypercholesterolemic atherogenesis

Sekar Ashok Kumar, Sudhahar Varadarajan, Palaninathan Varalakshmi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The aim of the present study is to evaluate the effect of eicosapentaenoic acid (EPA), dl-α-lipoic acid (LA) and eicosapentaenoate-lipoate (EPA-LA) derivative on the atherogenic disturbances in hypercholesterolemic atherogenic animals. Eight groups of male Wistar rats were employed in this study, wherein four groups were fed with a high cholesterol diet (rat chow supplemented with 4% cholesterol and 1% cholic acid; HCD) for 30 days, among which, three groups of rats were also treated with either EPA (35 mg/kg body weight/day, oral gavage), LA (20 mg/kg body weight/day, oral gavage) or EPA-LA derivative (50 mg/kg body weight/day, oral gavage) commencing from 16th day of the experimental period. The remaining four groups served as control and EPA, LA and EPA-LA derivative treated drug controls. Abnormal increases in the levels of malondialdehyde, protein carbonyl and 8-hydroxy-2-deoxyguanosine, as well as depressed antioxidants status, were observed in hepatic tissue of HCD fed rats. HCD induced abnormal elevation in the activities of hepatic lactate dehydrogenase, aminotransferases and alkaline phosphatase (ALP) and was accompanied by increased hepatic cholesterol level and altered fatty changes in the histology of liver. These changes were restored partially in the EPA and LA administered groups. However, the combined derivative EPA-LA almost ameliorated the hypercholesterolemic-oxidative changes in the HCD fed rats. The results of this study present oxidative injury induced by hypercholesterolemic diet and administration of the combination treatment of EPA-LA afforded sound protection against lipemic-oxidative injury.

Original languageEnglish (US)
Pages (from-to)115-122
Number of pages8
JournalAtherosclerosis
Volume189
Issue number1
DOIs
StatePublished - Nov 1 2006

Fingerprint

Thioctic Acid
Eicosapentaenoic Acid
Atherosclerosis
Wounds and Injuries
Liver
Cholesterol
Body Weight
Diet
Cholic Acid
Drug and Narcotic Control
Transaminases
Malondialdehyde
L-Lactate Dehydrogenase
Alkaline Phosphatase
Wistar Rats
Histology
Antioxidants
eicosapentaenoate-lipoate
Proteins
Therapeutics

Keywords

  • Antioxidant
  • Eicosapentaenoic acid
  • Hypercholesterolemia
  • Lipoic acid

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Protective role of eicosapentaenoate-lipoate (EPA-LA) derivative in combating oxidative hepatocellular injury in hypercholesterolemic atherogenesis. / Kumar, Sekar Ashok; Varadarajan, Sudhahar; Varalakshmi, Palaninathan.

In: Atherosclerosis, Vol. 189, No. 1, 01.11.2006, p. 115-122.

Research output: Contribution to journalArticle

@article{753f29959a0048c1ae79b0fc3fc925f9,
title = "Protective role of eicosapentaenoate-lipoate (EPA-LA) derivative in combating oxidative hepatocellular injury in hypercholesterolemic atherogenesis",
abstract = "The aim of the present study is to evaluate the effect of eicosapentaenoic acid (EPA), dl-α-lipoic acid (LA) and eicosapentaenoate-lipoate (EPA-LA) derivative on the atherogenic disturbances in hypercholesterolemic atherogenic animals. Eight groups of male Wistar rats were employed in this study, wherein four groups were fed with a high cholesterol diet (rat chow supplemented with 4{\%} cholesterol and 1{\%} cholic acid; HCD) for 30 days, among which, three groups of rats were also treated with either EPA (35 mg/kg body weight/day, oral gavage), LA (20 mg/kg body weight/day, oral gavage) or EPA-LA derivative (50 mg/kg body weight/day, oral gavage) commencing from 16th day of the experimental period. The remaining four groups served as control and EPA, LA and EPA-LA derivative treated drug controls. Abnormal increases in the levels of malondialdehyde, protein carbonyl and 8-hydroxy-2-deoxyguanosine, as well as depressed antioxidants status, were observed in hepatic tissue of HCD fed rats. HCD induced abnormal elevation in the activities of hepatic lactate dehydrogenase, aminotransferases and alkaline phosphatase (ALP) and was accompanied by increased hepatic cholesterol level and altered fatty changes in the histology of liver. These changes were restored partially in the EPA and LA administered groups. However, the combined derivative EPA-LA almost ameliorated the hypercholesterolemic-oxidative changes in the HCD fed rats. The results of this study present oxidative injury induced by hypercholesterolemic diet and administration of the combination treatment of EPA-LA afforded sound protection against lipemic-oxidative injury.",
keywords = "Antioxidant, Eicosapentaenoic acid, Hypercholesterolemia, Lipoic acid",
author = "Kumar, {Sekar Ashok} and Sudhahar Varadarajan and Palaninathan Varalakshmi",
year = "2006",
month = "11",
day = "1",
doi = "10.1016/j.atherosclerosis.2005.11.037",
language = "English (US)",
volume = "189",
pages = "115--122",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Protective role of eicosapentaenoate-lipoate (EPA-LA) derivative in combating oxidative hepatocellular injury in hypercholesterolemic atherogenesis

AU - Kumar, Sekar Ashok

AU - Varadarajan, Sudhahar

AU - Varalakshmi, Palaninathan

PY - 2006/11/1

Y1 - 2006/11/1

N2 - The aim of the present study is to evaluate the effect of eicosapentaenoic acid (EPA), dl-α-lipoic acid (LA) and eicosapentaenoate-lipoate (EPA-LA) derivative on the atherogenic disturbances in hypercholesterolemic atherogenic animals. Eight groups of male Wistar rats were employed in this study, wherein four groups were fed with a high cholesterol diet (rat chow supplemented with 4% cholesterol and 1% cholic acid; HCD) for 30 days, among which, three groups of rats were also treated with either EPA (35 mg/kg body weight/day, oral gavage), LA (20 mg/kg body weight/day, oral gavage) or EPA-LA derivative (50 mg/kg body weight/day, oral gavage) commencing from 16th day of the experimental period. The remaining four groups served as control and EPA, LA and EPA-LA derivative treated drug controls. Abnormal increases in the levels of malondialdehyde, protein carbonyl and 8-hydroxy-2-deoxyguanosine, as well as depressed antioxidants status, were observed in hepatic tissue of HCD fed rats. HCD induced abnormal elevation in the activities of hepatic lactate dehydrogenase, aminotransferases and alkaline phosphatase (ALP) and was accompanied by increased hepatic cholesterol level and altered fatty changes in the histology of liver. These changes were restored partially in the EPA and LA administered groups. However, the combined derivative EPA-LA almost ameliorated the hypercholesterolemic-oxidative changes in the HCD fed rats. The results of this study present oxidative injury induced by hypercholesterolemic diet and administration of the combination treatment of EPA-LA afforded sound protection against lipemic-oxidative injury.

AB - The aim of the present study is to evaluate the effect of eicosapentaenoic acid (EPA), dl-α-lipoic acid (LA) and eicosapentaenoate-lipoate (EPA-LA) derivative on the atherogenic disturbances in hypercholesterolemic atherogenic animals. Eight groups of male Wistar rats were employed in this study, wherein four groups were fed with a high cholesterol diet (rat chow supplemented with 4% cholesterol and 1% cholic acid; HCD) for 30 days, among which, three groups of rats were also treated with either EPA (35 mg/kg body weight/day, oral gavage), LA (20 mg/kg body weight/day, oral gavage) or EPA-LA derivative (50 mg/kg body weight/day, oral gavage) commencing from 16th day of the experimental period. The remaining four groups served as control and EPA, LA and EPA-LA derivative treated drug controls. Abnormal increases in the levels of malondialdehyde, protein carbonyl and 8-hydroxy-2-deoxyguanosine, as well as depressed antioxidants status, were observed in hepatic tissue of HCD fed rats. HCD induced abnormal elevation in the activities of hepatic lactate dehydrogenase, aminotransferases and alkaline phosphatase (ALP) and was accompanied by increased hepatic cholesterol level and altered fatty changes in the histology of liver. These changes were restored partially in the EPA and LA administered groups. However, the combined derivative EPA-LA almost ameliorated the hypercholesterolemic-oxidative changes in the HCD fed rats. The results of this study present oxidative injury induced by hypercholesterolemic diet and administration of the combination treatment of EPA-LA afforded sound protection against lipemic-oxidative injury.

KW - Antioxidant

KW - Eicosapentaenoic acid

KW - Hypercholesterolemia

KW - Lipoic acid

UR - http://www.scopus.com/inward/record.url?scp=33748981807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748981807&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2005.11.037

DO - 10.1016/j.atherosclerosis.2005.11.037

M3 - Article

C2 - 16458314

AN - SCOPUS:33748981807

VL - 189

SP - 115

EP - 122

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -